The ACTION - Achieving Control Through Insulin plus Oral ageNts brand, founded in 2006 (Denmark), from 307 sister brands and 2214 competing brands. ACTION - Achieving Control Through Insulin plus Oral ageNts is owned by NOVO-NORDISK A/S, listed on the stock exchange of Francfort The sector of ACTION - Achieving Control Through Insulin plus Oral ageNts is Biotechnology.
Share price and profitability of the share NOVO-NORDISK A/S (ACTION - Achieving Control Through Insulin plus Oral ageNts)
Buy NOVO-NORDISK A/S share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
NOVO-NORDISK A/S
(ACTION - Achieving Control Through Insulin plus Oral ageNts)
over 5 years*
EUR 625.86
Stock market history NOVO-NORDISK A/S (ACTION - Achieving Control Through Insulin plus Oral ageNts)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
